Evidence map›Paper›PMID 28479724›Full record

ArticlePharmacognosy magazine2017

Cytotoxic Metabolites from

Tariq R A Sobahi, Seif-Eldin N Ayyad, Ahmed Abdel-Lateff, Mardi M Algandaby, Hajer S Alorfi, Ashraf B Abdel-Naim

Abstract read
In one paragraph

Article in Pharmacognosy magazine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Red Sea SpongeOncoTargets and therapy · 2024
    Article
  3. Metabolites · 2023
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Tariq R A SobahiDepartment of Chemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
Seif-Eldin N AyyadDepartment of Chemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
Ahmed Abdel-LateffDepartment of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Mardi M AlgandabyDepartment of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
Hajer S AlorfiDepartment of Chemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
Ashraf B Abdel-NaimDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
King Abdulaziz University · SADamietta University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate the antiproliferative effect of the isolated metabolites from

methodsDifferent chromatographic methods have been done on the organic extract of the marine sponge aiming at isolating the bioactive metabolites. The cytotoxicity of the isolated compounds has been evaluated against the human colorectal cancer cell line; HCT-116, employing SRB assay. The flow cytometry assay was applied to measure the cell cycle analysis.

resultsSix metabolites (1-6) were obtained. The compounds 4-6 exhibited IC

conclusionsThe antiproliferative activity of 5 and 6 can be recognized, at least partly, due to their ability to induce cellular apoptosis. SUMMARY: Several metabolites were isolated from the marine sponge Callyspongia siphonella. Sipholenol A and sipholenol L exhibited effective cytotoxicity against HCT-116 cells. The observed cytotoxicity involves induction of cellular apoptosis.

Indexed as

AntiproliferativeCallyspongia siphonellaHCT-116marinesponge

Identifiers

PMID28479724
PMCPMC5407114
OpenAlexW2606421048

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.